Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Common drug review"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Search alternatives
:
common drug »
common due
Showing
141
-
160
of
790
Search:
'"Common drug review"'
,
query time: 0.07s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
141
Clinical review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus
Published 2019
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
142
Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus
Published 2019
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
143
Clinical review report: Tapentadol hydrochloride extended-release tablet (Nucynta extended-release) : (Paladin labs inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
144
Clinical review report: Dapagliflozin (Forxiga)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
145
CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
146
Pharmacoeconomic review report: Adalimumab (Humira)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
147
Clinical review report: Emtricitabine/tenofovir alafenamide fumarate (Descovy)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
148
Pharmacoeconomic review report: Dapagliflozin (Forxiga)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
149
Pharmacoeconomic review report: Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
150
Clinical review report: Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
151
Clinical review report: Caplacizumab (Cablivi) : (Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of adults with acquired throm...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
152
CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris -- Alexion Pharma Canada Corp.) : indication : adult patients with refractory generalized myasthenia gravis
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
153
CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada Corp.) : indication : the treatment of neuromyelitis optica spectrum disorder (NMOS...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
154
Clinical review report: Emtricitabine/tenofovir alafenamide fumarate (Descovy)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
155
Clinical review report: Riociguat (Adempas)
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
156
Pharmacoeconomic review report: Sapropterin dihydrochloride (Kuvan)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
157
Pharmacoeconomic review report: Omalizumab (Xolair)
Published 2017
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
158
Pharmacoeconomic report: Halobetasol propionate and tazarotene (Duobrii) : (Bausch Health, Canada Inc.) :indica tion: psoriasis, moderate-to-severe plaque
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
159
CADTH Canadian Drug Expert Committee recommendation: Etonogestrel extended-release subdermal implant (Nexplanon -- Merck Canada Inc.) : indication : prevention of pregnancy for up...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
160
Clinical review report: Nintedanib (Ofev) (Boehringer Ingelheim Canada Ltd.) : indication: chronic fibrosing interstitial lung diseases
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
3
4
5
6
7
8
9
10
11
12
13
Back
Narrow Search
Year of Publication
From:
To:
Classification
610 - Medicine & health
581
330 - Economics
256
140 - Specific philosophical schools
83
700 - The arts; fine & decorative arts
76
580 - Plants (Botany)
11
380 - Commerce, communications & transportation
7
more ...
615 - Pharmacology & therapeutics
4
see all ...
less ...
Language
English
790
Collection
National Center for Biotechnology Information
790
Author
Canadian Agency for Drugs and Technologies in Health
729
CADTH Canadian Drug Expert Committee
210
Canadian Diabetes Association
4
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=8&lookfor=%22Common+drug+review%22&type=Series
Send by Email
×
Loading...